Home › NDC Lookup › RxCUI directory › RxCUI 199206

Riluzole 50 MG Oral Tablet — RxCUI 199206

RxNorm drug concept · Semantic clinical drug
RxCUI 199206 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI199206
Official nameRiluzole 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped5
Package NDCs mapped13
Reported Medicaid activity (SDUD)3,628 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Riluzole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Riluzole treats amyotrophic lateral sclerosis (ALS). It comes as tablets and as an oral liquid called Tiglutik. Doctors don’t know exactly how it works in ALS.
  • Take it twice a day, about 12 hours apart, at least 1 hour before or 2 hours after a meal. If you use Tiglutik, shake the bottle gently for 30 seconds first. It can be taken by mou...
  • Riluzole can raise liver enzymes and, rarely, cause serious liver injury. Your doctor will check them before you start, monthly for the first 3 months, and periodically after that.
  • Why do I need blood tests while on riluzole?
📖 Read our full Riluzole guide →

🕸️ Concept Web — How Riluzole 50 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Riluzole 50 MG Oral Tablet RxCUI 199206

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Riluzole 35623
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Rilutek 196501
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Riluzole Oral Tablet 373787
    • Riluzole Oral Product 1165471
    • Riluzole Pill 1165472
    • Riluzole Oral Tablet [Rilutek] 368026
    • Rilutek Oral Product 1184724
    • Rilutek Pill 1184725
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Riluzole 50 MG 317486
    • Riluzole 50 MG Oral Tablet [Rilutek] 152915
    • Riluzole 50 MG [Rilutek] 565105

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Riluzole 50 MG SCDC · 317486
  • Riluzole Oral Tablet SCDF · 373787
  • Riluzole Oral Product SCDG · 1165471
  • Riluzole Pill SCDG · 1165472

Brand-Name Concepts

  • Riluzole 50 MG Oral Tablet [Rilutek] SBD · 152915
  • Riluzole 50 MG [Rilutek] SBDC · 565105
  • Riluzole Oral Tablet [Rilutek] SBDF · 368026
  • Rilutek Oral Product SBDG · 1184724
  • Rilutek Pill SBDG · 1184725
  • Rilutek BN · 196501

📦 FDA Products & Package NDCs

5 products · 13 package NDCs
13 package NDCs map to RxCUI 199206 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42291-0775-60 60 TABLET, FILM COATED in 1 BOTTLE (42291-775-60) Riluzole AvKARE 2020-10-07
62756-0538-18 1000 TABLET, FILM COATED in 1 BOTTLE (62756-538-18) Riluzole Sun Pharmaceutical Industries, Inc. 2013-06-18
62756-0538-83 30 TABLET, FILM COATED in 1 BOTTLE (62756-538-83) Riluzole Sun Pharmaceutical Industries, Inc. 2013-06-18
62756-0538-86 60 TABLET, FILM COATED in 1 BOTTLE (62756-538-86) Riluzole Sun Pharmaceutical Industries, Inc. 2013-06-18
62756-0538-88 100 TABLET, FILM COATED in 1 BOTTLE (62756-538-88) Riluzole Sun Pharmaceutical Industries, Inc. 2013-06-18
67877-0286-05 500 TABLET in 1 BOTTLE (67877-286-05) Riluzole Ascend Laboratories, LLC 2016-03-31
67877-0286-10 1000 TABLET in 1 BOTTLE (67877-286-10) Riluzole Ascend Laboratories, LLC 2016-03-31
67877-0286-14 10 BLISTER PACK in 1 CARTON (67877-286-14) / 14 TABLET in 1... Riluzole Ascend Laboratories, LLC 2016-03-31
67877-0286-60 60 TABLET in 1 BOTTLE (67877-286-60) Riluzole Ascend Laboratories, LLC 2016-03-31
67877-0286-90 90 TABLET in 1 BOTTLE (67877-286-90) Riluzole Ascend Laboratories, LLC 2016-03-31
68462-0381-10 1000 TABLET, FILM COATED in 1 BOTTLE (68462-381-10) riluzole Glenmark Pharmaceuticals Inc., USA 2013-06-18
68462-0381-60 60 TABLET, FILM COATED in 1 BOTTLE (68462-381-60) riluzole Glenmark Pharmaceuticals Inc., USA 2013-06-18
69076-0200-60 60 TABLET, FILM COATED in 1 BOTTLE (69076-200-60) RILUZOLE Florida Pharmaceutical Products, LLC 2020-01-01
Observed labelers: Ascend Laboratories, LLC (5) · Sun Pharmaceutical Industries, Inc. (4) · Glenmark Pharmaceuticals Inc., USA (2) · AvKARE (1) · Florida Pharmaceutical Products, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.